IDSA needs your help in putting a human face on the problem of antimicrobial resistance and in advancing the Society’s 10 x ‘20 initiative, which calls for a global commitment to develop 10 new antibiotics by 2020 (see related IDSA News article). To educate the public, policymakers, and the media about the threat posed by drug-resistant infections and the lack of new drugs to treat them, IDSA, with help from its members, is trying to identify patients who are willing to share their experiences, particularly those involving multi-drug resistant (MDR) gram-negative bacteria and methicillin-resistant staphylococcal aureus (MRSA).
“We have an emerging health care crisis; the absence of effective drugs is a critical unmet medical need; and we need to get this message to the public,” said David Gilbert, MD, FIDSA, chair of IDSA’s Antibiotic Availability Task Force (AATF), in an e-mail to IDSA members earlier this month. “There is no way to achieve this goal without representative patients.”
Patient stories are needed to share with the media and to post on IDSA’s website. IDSA members should, in compliance with Health Insurance Portability and Accountability Act (HIPAA) regulations, reach out to potential patients or family members to discuss their willingness to share their experiences and, if they agree, submit their contact information to Padma Natarajan, IDSA’s program officer for science and research, at firstname.lastname@example.org. Members of IDSA staff will then follow up with individual patients.
< Previous Article | Next Article >